Lead Public Health Concepts

Pfizer has initiated some cardiovascular disease management programs to address public health challenges. Pfizer has collaborated with the government, healthcare providers and institutions to explore innovative solutions to improve the cardiovascular disease management in China. On April 16th, 2013, the 4th Chinese Chronic Disease Management Conference 2013 was successfully held in Beijing. Pfizer China regional president Dr. Wu Xiaobing made an appeal to the public to pay attention to heart and brain health on the conference. Pfizer China launched three government-led initiatives about chronic diseases prevention and control:

1. carry on a national dyslipidemia screening
2. establish a national day about chronic disease prevention and control
3.implement effective measures for tobacco control

Pfizer calls on for multilateral cooperation to jointly promote chronic disease management to create a healthier China in 2020!

A Health Development Symposium, which was supported by Pfizer China and hosted by the Beijing Institute of Health Economics, was successfully held in Beijing on July 31, 2013. The symposium focused on key health development topics and greatly enhanced healthcare management and related academic researches. The Symposium also lent support to healthcare development in Beijing.

Pfizer China supported Chinese Association on Tobacco Control to a series of women tobacco control programs from 2012 to 2013. The programs collected signatures of 600 women celebrities who called on women nationwide to stop second-hand smoking. More than 1,600 women maternity and community healthcare professionals as well as enterprise delegates in Beijing have received tobacco control trainings.